| Title |
VISTA: A Promising Target for Cancer Immunotherapy?
|
|---|---|
| Published in |
ImmunoTargets and Therapy, June 2021
|
| DOI | 10.2147/itt.s260429 |
| Pubmed ID | |
| Authors |
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, Mariana Brandão, Francesca Poggio, Alfredo Addeo, Matteo Lambertini |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Belgium | 3 | 14% |
| Italy | 3 | 14% |
| Korea, Republic of | 1 | 5% |
| United Kingdom | 1 | 5% |
| United States | 1 | 5% |
| Spain | 1 | 5% |
| Colombia | 1 | 5% |
| Switzerland | 1 | 5% |
| Brazil | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 8 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 57% |
| Practitioners (doctors, other healthcare professionals) | 5 | 24% |
| Scientists | 4 | 19% |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 54 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 13% |
| Student > Bachelor | 6 | 11% |
| Student > Ph. D. Student | 6 | 11% |
| Student > Master | 3 | 6% |
| Professor | 2 | 4% |
| Other | 4 | 7% |
| Unknown | 26 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 17% |
| Biochemistry, Genetics and Molecular Biology | 7 | 13% |
| Nursing and Health Professions | 2 | 4% |
| Immunology and Microbiology | 2 | 4% |
| Agricultural and Biological Sciences | 1 | 2% |
| Other | 5 | 9% |
| Unknown | 28 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#2,303,260
of 25,784,004 outputs
Outputs from ImmunoTargets and Therapy
#13
of 127 outputs
Outputs of similar age
#57,351
of 462,290 outputs
Outputs of similar age from ImmunoTargets and Therapy
#3
of 11 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 127 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,290 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.